Raymond James & Associates Bausch Health Companies Inc. Call Options Transaction History

Raymond James & Associates

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $395,360 - $1.32 Million	-56,000 Reduced 57.14%	42,000 $7,000
Q1 2022 May 11, 2022	BUY	$21.6 - $27.79 $864,000 - $1.11 Million	40,000 Added 68.97%	98,000 $254,000
Q2 2021 Aug 11, 2021	SELL	$27.43 - $32.7 $54,860 - $65,400	-2,000 Reduced 3.33%	58,000 $563,000
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $1.7 Million - $2.74 Million	-79,600 Reduced 57.02%	60,000 $729,000
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $1.97 Million - $2.72 Million	129,000 Added 1216.98%	139,600 $339,000
Q4 2019 Feb 12, 2020	SELL	$18.89 - $31.89 $64,226 - $108,426	-3,400 Reduced 24.29%	10,600 $23,000
Q4 2018 Feb 11, 2019	SELL	$17.64 - $28.32 $246,960 - $396,480	-14,000 Reduced 50.0%	14,000 $50,000
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $577,920 - $718,760	28,000 New	28,000 $171,000

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.96B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.